Human papillomavirus and oropharyngeal cancer: What you need to know in 2009

Current Treatment Options in Oncology

Volumn 10, Issue 5-6, 2009, Pages 296-307

  Gillespie, M Boyd ^a   Rubinchik, Semyon ^a   Hoel, Brian ^a   Sutkowski, Natalie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPSID PROTEIN L1; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PROTEIN E6; PROTEIN E7; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS DNA; VIRUS RNA; WART VIRUS VACCINE;

CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; GENE MUTATION; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HUMAN; LARYNX CANCER; LASER CAPTURE MICRODISSECTION; NECK METASTASIS; NONHUMAN; OROPHARYNX CANCER; PATIENT EDUCATION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TONSIL CANCER; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS GENOME; VIRUS TRANSMISSION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; ANTIBODIES, VIRAL; CARCINOMA, SQUAMOUS CELL; CHILD; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INCIDENCE; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SEXUAL BEHAVIOR; SURVIVAL RATE;

EID: 77951022892     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-009-0113-5     Document Type: Review

References (36)

1. Ferlay J, Bray F, Pisani P, Parkin DM: Globocan 2002: Cancer Incidence and Mortality Worldwide. IARC Cancer Base No. 5, Version 2.0. Lyon, France: IARC; 2004.
2. Sheinin R: Viruses: causative agents of cancer. Laryngoscope 1975, 85:468-486.
3. Lindeberg H, Fey SJ, Ottosen PD, Mose Larsen P: Human papilloma virus (HPV) and carcinomas of the head and neck. Clin Otolaryngol Allied Sci 1988, 13:447-454.
4. Brandwein MS, Nuovo GS, Biller H: Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 1993, 102:309-313.
5. Park NH, Min BM, Li SL, et al.: Immortalization of normal oral human keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991, 12:1627-1631.
6. Schiffman M, Castle PE, Jeronimo J, et al.: Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907
7. Doorbar J: Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006, 110:525-541.
8. B̈ Mork J, Lie K, Glattre E, et al.: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344:1125-1131.
9. Herrero R, Castellsague X, Pawlita M, et al.: Human papillomavirus and oral cancer: the International Agency for Research on Cancer Multicenter Study. J Natl Can Inst 2003, 95:1772-1783.
10. Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467-475.
11. Begum S, Cao D, Gillison M, et al.: Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005, 11:5694-5699.
12. Califano J, van der Reit P, Westra W, et al.: Genetc progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488-2492.
13. Weinberger PM, Yu Z, Haffty BG, et al.: Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006, 24:736-747.
14. Rose BR, Li W, O'Brien CJ: Human papillomvirus: a cause of some head and neck cancers? Med J Aust 2004, 181:415-416.
15. Shiboski CH, Schmidt BL, Jordan RC: Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005, 103:1843-1849.
16. Sturgis EM, Cinciripini PM: Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirusassociated cancer? Cancer 2007, 110:1429-1435.
17. Hammarstedt L, Lindquist D, Dahlstrand H, et al.: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006, 119:2620-2623.
18. Anaya-Saavedra G, Ramirez-Amador V, Irigoyen-Camacho E, et al.: High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res 2008, 39:189-197.
19. Gillison ML, D'Souza G, Westra W, et al.: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008, 100:407-420.
20. Psyrri A, DiMaio D: Human papillomavirus in cervical and head-and-neck cancer. Nature Clin Prac 2008, 5:24-31.
21. Goldenberg D, Begum S, Westra WH, et al.: Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008, 30:898-903.
22. Fakhry C, Westra W, Li S, et al.: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100: 261-269.
23. Nichols AC, Faquin WC, Westra WH, et al.: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009, 140:228-234.
24. Klozar J, Kratochvil V, Salakova M, et al.: HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 2007, 20: Epub ahead of print.
25. Ragin CCR, Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007, 121:1813-1820.
26. Settle K, Posner MR, Schumaker LM, et al.: Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res 2009, 2:OF1-6.
27. Licitra L, Perrone F, Bossi P, et al.: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncil 2006, 24:5630-5636.
28. Hafkamp HC, Manni JJ, Haesevoets A, et al.: Marked differences in survival rates between smokers and nonsmokers and HPV 16-associated tonsillar carcinomas. Int J Cancer 2008, 122:2656-2664.
29. Westra WH, Taube JM, Poeta ML, et al.: Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 2008, 14:366-369.
30. Pradier O, Christiansen H, Schmidberger H, et al.: Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phy 2005, 63:1368-1377.
31. Begum S, Gillison ML, Ansari-Lari MA, et al.: Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003, 9:6469-6475.
32. Roh JL, Kim JS, Lee JH, et al.: Utility of combined (18)F- fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009, 45:218-224.
33. KochWM, Bhatti N,WilliamsMF, EiseleDW: Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001, 124:331-333.
34. Miller CS, Johnstone BM: Human papillomavirus as a risk factor for oral squamous cell carcinoma: a metaanalysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:622-635.
35. Smith EM, Swarnavel S, Ritchie JM, et al.: Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J. 2007, 26:836-840.
36. Giuliano AR, Harris R, Sedjo RL, et al.: Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis 2002, 186:462-469.